Douglas Tsao
Stock Analyst at H.C. Wainwright
(4.93)
# 188
Out of 4,835 analysts
1199
Total ratings
55.8%
Success rate
26.4%
Average return
Main Sectors:
Stocks Rated by Douglas Tsao
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHVN Biohaven | Reiterated: Hold | $10 | $12.71 | -21.32% | 24 | Sep 10, 2026 | |
| IRON Disc Medicine | Reiterated: Buy | $120 | $70.06 | +71.28% | 40 | Sep 10, 2026 | |
| ROIV Roivant Sciences | Rated: Buy | $41 → $47 | $40.82 | +15.14% | 48 | Sep 9, 2026 | |
| RZLT Rezolute | Reiterated: Buy | $5 | $4.22 | +18.48% | 47 | Sep 9, 2026 | |
| CABA Cabaletta Bio | Reiterated: Buy | $16 | $2.73 | +486.08% | 51 | Sep 1, 2026 | |
| PTGX Protagonist Therapeutics | Rated: Buy | $167 → $170 | $148.18 | +14.73% | 80 | Sep 1, 2026 | |
| EOLS Evolus | Reiterated: Buy | $13 | $7.84 | +65.82% | 57 | Aug 25, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,202 | $984.39 | +22.11% | 69 | Aug 24, 2026 | |
| NMRA Neumora Therapeutics | Reiterated: Buy | $7 | $1.04 | +573.08% | 26 | Aug 24, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | $66 | $43.62 | +51.31% | 13 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $360 → $1.2 | $0.3269 | +267.08% | 10 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $0.706 | +1,599.72% | 41 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 | $17.02 | -0.12% | 41 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $23.89 | +42.35% | 20 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $41 | $37.36 | +9.74% | 46 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $4.30 | +62.69% | 44 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,201 | $334.58 | +258.96% | 56 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 | $58.65 | +26.17% | 17 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $21.24 | +3.58% | 31 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.33 | +426.32% | 78 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $25.22 | +50.70% | 30 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $43 | $45.87 | -6.26% | 60 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $0.5 → $1.6 | $0.66 | +142.42% | 48 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 103.00 | kr 40.50 | +154.32% | 52 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.73 | +304.62% | 13 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $125 → $5 | $0.0004 | n/a | 26 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $0.000001 | n/a | 13 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $14.25 | n/a | 4 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.16 | n/a | 19 | Nov 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €19.00 → €11.00 | €3.65 | n/a | 7 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $37.09 | n/a | 12 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $31 → $33 | $35.62 | n/a | 2 | Jul 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $93 → $80 | $13.66 | n/a | 8 | Jun 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40.12 | $8.10 | n/a | 17 | Jun 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $17.01 | n/a | 2 | May 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $71 → $77 | $72.97 | n/a | 6 | Feb 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $108 → $120 | $169.31 | n/a | 12 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $120 | $258.17 | n/a | 3 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $107.20 | n/a | 3 | Jun 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $47 → $50 | $16.51 | n/a | 6 | May 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $245.80 | n/a | 7 | Jan 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $276.83 | n/a | 5 | Nov 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $14 → $2 | $14.73 | n/a | 5 | Nov 16, 2016 |
Biohaven
Sep 10, 2026
Reiterated: Hold
Price Target: $10
Current: $12.71
Upside: -21.32%
Disc Medicine
Sep 10, 2026
Reiterated: Buy
Price Target: $120
Current: $70.06
Upside: +71.28%
Roivant Sciences
Sep 9, 2026
Rated: Buy
Price Target: $41 → $47
Current: $40.82
Upside: +15.14%
Rezolute
Sep 9, 2026
Reiterated: Buy
Price Target: $5
Current: $4.22
Upside: +18.48%
Cabaletta Bio
Sep 1, 2026
Reiterated: Buy
Price Target: $16
Current: $2.73
Upside: +486.08%
Protagonist Therapeutics
Sep 1, 2026
Rated: Buy
Price Target: $167 → $170
Current: $148.18
Upside: +14.73%
Evolus
Aug 25, 2026
Reiterated: Buy
Price Target: $13
Current: $7.84
Upside: +65.82%
argenx SE
Aug 24, 2026
Reiterated: Buy
Price Target: $1,202
Current: $984.39
Upside: +22.11%
Neumora Therapeutics
Aug 24, 2026
Reiterated: Buy
Price Target: $7
Current: $1.04
Upside: +573.08%
Rapport Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $66
Current: $43.62
Upside: +51.31%
Aug 14, 2026
Reiterated: Buy
Price Target: $360 → $1.2
Current: $0.3269
Upside: +267.08%
Aug 14, 2026
Reiterated: Buy
Price Target: $12
Current: $0.706
Upside: +1,599.72%
Aug 11, 2026
Reiterated: Hold
Price Target: $17
Current: $17.02
Upside: -0.12%
Aug 10, 2026
Reiterated: Buy
Price Target: $34
Current: $23.89
Upside: +42.35%
Aug 10, 2026
Reiterated: Buy
Price Target: $40 → $41
Current: $37.36
Upside: +9.74%
Aug 10, 2026
Reiterated: Hold
Price Target: $7
Current: $4.30
Upside: +62.69%
Aug 10, 2026
Reiterated: Buy
Price Target: $1,201
Current: $334.58
Upside: +258.96%
Aug 10, 2026
Reiterated: Buy
Price Target: $74
Current: $58.65
Upside: +26.17%
Aug 7, 2026
Reiterated: Buy
Price Target: $22
Current: $21.24
Upside: +3.58%
Aug 6, 2026
Reiterated: Buy
Price Target: $7
Current: $1.33
Upside: +426.32%
Aug 5, 2026
Reiterated: Buy
Price Target: $38
Current: $25.22
Upside: +50.70%
Jul 29, 2026
Reiterated: Hold
Price Target: $43
Current: $45.87
Upside: -6.26%
Jul 28, 2026
Rated: Hold
Price Target: $0.5 → $1.6
Current: $0.66
Upside: +142.42%
Jul 24, 2026
Reiterated: Buy
Price Target: kr 103.00
Current: kr 40.50
Upside: +154.32%
Nov 6, 2025
Reiterated: Buy
Price Target: $7
Current: $1.73
Upside: +304.62%
Nov 14, 2024
Downgraded: Hold
Price Target: $125 → $5
Current: $0.0004
Upside: n/a
Aug 21, 2023
Reiterated: Buy
Price Target: $4 → $3
Current: $0.000001
Upside: n/a
Mar 8, 2023
Reiterated: Hold
Price Target: $6
Current: $14.25
Upside: n/a
Nov 30, 2022
Rated: Hold
Price Target: n/a
Current: $2.16
Upside: n/a
Nov 1, 2022
Reiterated: Buy
Price Target: €19.00 → €11.00
Current: €3.65
Upside: n/a
Aug 6, 2018
Reiterated: Hold
Price Target: $23
Current: $37.09
Upside: n/a
Jul 3, 2018
Reiterated: Sell
Price Target: $31 → $33
Current: $35.62
Upside: n/a
Jun 6, 2018
Downgraded: Hold
Price Target: $93 → $80
Current: $13.66
Upside: n/a
Jun 6, 2018
Upgraded: Buy
Price Target: $40.12
Current: $8.10
Upside: n/a
May 1, 2018
Initiated Coverage: Buy
Price Target: $27
Current: $17.01
Upside: n/a
Feb 16, 2018
Reiterated: Hold
Price Target: $71 → $77
Current: $72.97
Upside: n/a
Oct 27, 2017
Reiterated: Hold
Price Target: $108 → $120
Current: $169.31
Upside: n/a
Oct 27, 2017
Reiterated: Buy
Price Target: $100 → $120
Current: $258.17
Upside: n/a
Jun 22, 2017
Reiterated: Buy
Price Target: $16
Current: $107.20
Upside: n/a
May 22, 2017
Upgraded: Buy
Price Target: $47 → $50
Current: $16.51
Upside: n/a
Jan 18, 2017
Reiterated: Buy
Price Target: $200
Current: $245.80
Upside: n/a
Nov 30, 2016
Upgraded: Hold
Price Target: n/a
Current: $276.83
Upside: n/a
Nov 16, 2016
Reiterated: Sell
Price Target: $14 → $2
Current: $14.73
Upside: n/a